HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and lowers the price target from $11 to $9.
Ekso Bionics Holdings (NASDAQ:EKSO) is set to give its latest quarterly earnings report on Thursday, 2022-07-28. Here's what investors need to know before the announcement.
Analysts estimate that Ekso Bionics Holdings will report an earnings per share (EPS) of $-0.24.